Free Trial

Joint Q4 2023 Earnings Report

Joint logo
$10.64 -0.33 (-3.01%)
(As of 04:00 PM ET)

Joint Earnings Headlines

Joint (NASDAQ:JYNT) May Have Issues Allocating Its Capital
Affordable AI Plays: 2 Stocks Under $10 with Huge Potential!
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
See More Joint Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Joint? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Joint and other key companies, straight to your email.

About Joint

Joint (NASDAQ:JYNT) operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

View Joint Profile

More Earnings Resources from MarketBeat

Upcoming Earnings